The Medicines and Healthcare products Regulatory Agency is warning the public about the dangers of buying weight-loss medicines from illegal online sources. The regulator says unregulated sellers continue to expose people to serious health risks through unsafe products.
The warning has been issued by the MHRA ahead of the New Year, when demand for weight-loss treatments often increases. It focuses on illegal online sales of prescription-only medicines, including GLP-1 treatments, and urges people to use legitimate, regulated suppliers.
The Medicines and Healthcare products Regulatory Agency has issued a New Year warning urging the public to avoid illegal online weight-loss medicines. The regulator says unregulated sellers often supply fake, contaminated or incorrectly dosed products, including prescription-only GLP-1 treatments. The warning highlights risks such as heart problems, psychological effects and dangerously low blood sugar. It also reinforces the importance of clinical assessment, regulated pharmacies and reporting suspicious sellers to protect patient safety.
Introduction
The Medicines and Healthcare products Regulatory Agency has warned people to take extra care when considering weight-loss medicines at the start of the year. The regulator says rising demand is being exploited by illegal online sellers.
The advice highlights serious safety risks linked to unregulated products and reminds the public that many weight-loss medicines require a valid prescription and professional oversight.
MHRA warning on illegal online weight-loss medicines
The MHRA says weight-loss products sold through unregulated websites or social media may be fake, contaminated or incorrectly dosed. Such products can contain powerful ingredients not listed on the packaging.
The regulator warns that misuse of these medicines has been linked to severe side effects, including heart complications, psychological effects and dangerously low blood sugar levels.
Risks Identified by the Regulator
| Product quality | Medicines may be counterfeit, contaminated or contain unlisted ingredients |
| Health effects | Use can lead to serious side effects including cardiac and metabolic complications |
Prescription-only weight-loss medicines and safe supply
Some medicines used for weight management, including all GLP-1 treatments, are prescription-only in the UK. The MHRA says these medicines should only be supplied following a proper clinical assessment.
Supplying or buying these treatments without a prescription removes safeguards designed to ensure the medicine is appropriate and safe for the individual.
- Prescription-only medicines require clinical assessment
- Unregulated supply increases the risk of misuse and harm
Safe Supply Requirements
| Clinical oversight | Assessment by a qualified healthcare professional before treatment is supplied |
| Legitimate sellers | Medicines obtained only from registered UK pharmacies or authorised retailers |
Advice to the public on buying medicines safely
The MHRA advises people to avoid weight-loss products promoted on social media, particularly those claiming quick results or unusually low prices. These are common indicators of illegal sellers.
People are encouraged to check pharmacy registration with the appropriate UK regulator and to report suspicious products or websites through the Yellow Card scheme.
- Avoid social media sellers and unverified websites
- Report suspicious products to the Yellow Card scheme
Ministerial Comments
Dr Zubir Ahmed, Health Minister said;
“Please do not buy weight loss medications from unregulated sources. These products are made with no regard for safety or quality and pose a major risk to customers.”
In Conclusion
The MHRA says people considering weight-loss treatment should seek advice from a GP, pharmacist or other qualified healthcare professional. Regulators stress that licensed medicines can be effective when used appropriately, but illegal online supply presents serious and avoidable risks.
The agency continues to encourage the public to use regulated pharmacies and to report unsafe products, particularly as demand for weight-loss treatments increases at the start of the year.
Sources: Medicines and Healthcare products Regulatory Agency.
Prepared by Ivan Alexander Golden, Founder of THX News™, an independent news organisation delivering timely insights from global official sources. Combines AI-analysed research with human-edited accuracy and context.
